![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 05, 2014 9:54:05 AM
Scientific Organizers: Gustavo Amarante-Mendes, Douglas R. Green and Kim Newton
October 28—November 2, 2014
Casa Grande Hotel, Guaruja, São Paulo, Brazil
-------------------------------------------------------------
have some fall clean ups to get to, so I just am posting what stood out to me initially. Will have to go thru all the affiliations with a fine tooth comb later ... but Japan seems to like PS Targeting and Takahashi is a very common Japanese name
------------------------------------------------------------
Wed Oct 29 2014
17:00—19:00
Cell Death Signaling II
Registered attendees can view abstracts starting on 09/28/2014
Beth Levine, University of Texas Southwestern Medical Center, USA
Autophagic Cell Death
Peter Vandenabeele, VIB, Ghent University, Belgium
Necroptosis versus Apoptosis
Sat Nov 1
* Peter Vandenabeele, VIB, Ghent University, Belgium
Shigekazu Nagata, Kyoto University, Japan
Exposure of phosphatidylserine during apoptosis
Closing Remarks:
* Gustavo P. Amarante-Mendes, Universidade de São Paulo, Brazil
*Session Chair †Speaker invited, not yet responded. (this looks like they invited "another" speaker as well ?? and not yet responded ?? if so... wonder who...)
Keystone Symposia thanks our Sponsors for generously supporting this meeting:
AbbVie Inc.
Genentech, Inc.
H3 Biomedicine Inc.
National Council for Scientific and Technological Development (CNPq) - Brazil
http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1321
....... we can't forget Beth Levine with certain ties to NDSU, just pointing it out since NDSU/Fargo had much to do with our little bump in the road
S Sinha1 and B Levine2,3,4
1Department of Chemistry, Biochemistry and Molecular Biology, North Dakota State University, Fargo,ND, USA
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
3Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA
4Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA
S Sinha: ude.usdn@ahnis.atignas; B Levine: ude.nretsewhtuoSTU@eniveL.hteB
Correspondence: Dr S Sinha, Department of Chemistry, Biochemistry and Molecular Biology, North Dakota State University, Fargo, ND, USA. B Levine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731580/#!po=68.3333
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM